What does BioNTech SE do?

BioNTech SE is a public company in the Biological Products, (No Diagnostic Substances) industry, incorporated in 2M. It is registered with the SEC under CIK 0001776985 and trades on NASDAQ under the ticker BNTX.

How many SEC filings has BioNTech SE made?

BioNTech SE has filed 530 documents with the SEC since 2019. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

BioNTech SE

BNTX NASDAQ CIK: 0001776985 Biological Products, (No Diagnostic Substances) Inc. in 2M

View on SEC.gov →

Overview All Filings Financials Insiders

Recent Filings

All 530 filings →

Form	Description	Date
3	FORM 3	Mar 25, 2026
3	FORM 3	Mar 25, 2026
3	FORM 3	Mar 25, 2026
3	FORM 3	Mar 25, 2026
3	FORM 3	Mar 25, 2026
3	FORM 3	Mar 25, 2026
3	FORM 3	Mar 25, 2026
6-K	6-K	Mar 24, 2026
3	3	Mar 18, 2026
3	3	Mar 18, 2026

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for BioNTech SE. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Financial data not yet loaded.

Details

CIK: 0001776985
Ticker: BNTX
Exchange: NASDAQ
Incorporated: 2M
First Filing: 2019
Total Filings: 530